Account Options

  1. Sign in
The old Google Groups will be going away soon, but your browser is incompatible with the new version.
Go to Google Groups Home
   
Discussions for Tibet Pharmaceuticals, Inc. View all discussions
My starred discussions
My profile

  Here is another TLON has FDA-ODAC -Meeting for Marqibo approval on 21st March2012
Only 1 message in discussion  - 
Reporting discussion
Messages reported
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
DINPAT2003@GMAIL.COM  
View profile  
 More options Feb 27 2012, 3:24 pm
From: "DINPAT2...@GMAIL.COM" <peterdeniel2...@gmail.com>
Date: Mon, 27 Feb 2012 12:24:48 -0800 (PST)
Local: Mon, Feb 27 2012 3:24 pm
Subject: Here is another TLON has FDA-ODAC -Meeting for Marqibo approval on 21st March2012
Print | Individual message | Report this message | Find messages by this author

Agenda

The committee will discuss New Drug Application (NDA) 202497, with the
proposed trade name Marqibo (vincristine sulfate liposomes injection),
application submitted by Talon Therapeutics, Incorporated. The
proposed indication (use) for this product is for the treatment of
adult patients with Philadelphia Chromosome-negative (Ph-) acute
lymphoblastic leukemia (ALL) in second or greater relapse or whose
disease has progressed following two or more treatment lines of anti-
leukemia therapy.

http://www.fda.gov/AdvisoryCommittees/Calendar/ucm290531.htm


 
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.

End of messages  

« Newer discussion  -  Tibet Pharma confirms $3/share   Not reliable because it is CHINA! PUDA CEO said he will buy all shares for $12 and he never did.. end up getting rid of his stocks only  -  Older discussion »




Google Home - Terms of Service - Privacy Policy

©2013 Google